186
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Prognostic models predicting overall survival of chronic lymphocytic leukemia (CLL) patients treated with ibrutinib-based therapies: a systematic review and meta-analysis

ORCID Icon &
Pages 889-892 | Received 03 Jan 2023, Accepted 09 Feb 2023, Published online: 27 Feb 2023
 

Author contributions

Stefano Molica and Diana Giannarelli designed the study and interpreted the data. Diana Giannarelli was responsible for statistical analysis. Stefano Molica wrote the paper and interpreted the data. All authors approved the manuscript.

Disclosure statement

SM received honoraria from Janssen, Abbvie, and AstraZeneca and advisory boards for Janssen, Abbvie, and AstraZeneca. DG nothing to declare. No potential conflict of interest was reported by the author(s).

Data availability statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.